nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Cognitive Disorders"

 

5-HT4-Receptor Agonists May Boost Cognitive Impairments Associated With Psychiatric Disorders
October 25, 2021   

Many psychiatric disorders include symptoms of cognitive impairment, which has been challenging to treat. Mounting evidence from animal studies suggest that the 5-HT4 receptor could be a promising potential treatment target for cognitive impairment because...
 Continue reading (Members only)
ADHD and Alzheimer’s Disease Across Generations
September 25, 2021   

Due to previous conflicting results regarding the association between attention-deficit hyperactivity disorder (ADHD) and Alzheimer’s disease (AD), a recent nationwide cohort study evaluated their link across generations. Index persons (N=2,132,929) born in Sweden were linked to their biological relatives: 4,246,182 index person-parent pairs....
 Continue reading (Members only)
Histamine 3 Receptor Inverse Agonist For Cognitive Disorders
February 26, 2021   

istamine H3 receptors, found throughout the cortex and hippocampus, have been hypothesized to be involved with cognition, learning, and memory. Several preclinical animal model studies have shown that H3 receptor antagonists/inverse agonists may have procognitive effects; however...
 Continue reading (Members only)
Systolic Orthostatic Hypotension Tied to Dementia Risk
August 21, 2020   

A recent study examined whether orthostatic hypotension and visit-to-visit blood pressure postural changes variability are associated with incident dementia. The study involved 2,131 people aged 73 years old on average. Repeatedly over a period of five years, researchers A recent study examined whether orthostatic hypotension and visit-to-visit blood pressure postural changes variability are associated with incident dementia. The study involved 2,131 people aged 73 years old on average. Over a period of five years, researchers...
 Continue reading (Members only)
Biogen Submits Application for US Approval for Alzheimer Drug
July 27, 2020   

Biogen completed the submission of a Biologics License Application for its monoclonal antibody aducanumab to the US Food and Drug Administration for the treatment of Alzheimer’s disease...
 Continue reading (Members only)
Pointing a Finger at Parkinson's Disease Dementia
January 12, 2018   

As many as 80% of patients with Parkinson's disease develop dementia (PDD)—a dementia that can be somewhat difficult to distinguish from Alzheimer's disease (AD). Appropriate diagnosis is key to planning as well as future application of disease-modifying treatments...
 Continue reading (Members only)
Ex-NFL Player Confirmed as First Case of Chronic Traumatic Encephalopathy in Living Patient
November 17, 2017   

New research appears to confirm that positron emission tomography (PET) imaging tracer can identify the distinctive brain tau pathology of chronic traumatic encephalopathy (CTE) in a living person....
 Continue reading (Members only)
Cognitive Remediation Can Improve Cognitive Function in Bipolar Disorder
November 3, 2017   

Cognitive remediation produced significant improvements over an active control in several cognitive domains...
 Continue reading
Combination Therapy Most Effective For Severe Pediatric Anxiety
October 23, 2017   

A recent secondary analysis of the Child/Adolescent Anxiety Multimodal Study (CAMS) was conducted to investigate predictors and moderators of pediatric anxiety...
 Continue reading (Members only)
Greater Cortical Thickness in Elderly Female Yoga Practitioners
July 22, 2017   

Yoga, mind-body activity has been associated with positive changes in brain structure and function, especially in areas related to attention, executive functions, and memory. Normal aging corresponds with structural and functional brain changes, that involve decreased cognitive function. In a recent cross-sectional study...
 Continue reading
12
Top of Page